Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era.

Lavie CJ, Milani RV.

J Am Coll Cardiol. 2008 Jan 1;51(1):56-8. doi: 10.1016/j.jacc.2007.08.055. No abstract available.

2.

High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench.

Levy Y.

Cardiovasc Res. 2008 Mar 1;77(4):614-5. doi: 10.1093/cvr/cvn003. Epub 2008 Jan 10. No abstract available.

PMID:
18187459
3.

["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].

Olsson AG, Nilsson PM.

Lakartidningen. 2009 Mar 18-24;106(12):854-7. Review. Swedish. No abstract available.

PMID:
19452786
4.

Increasing HDL Cholesterol Levels.

Brewer HB Jr.

N Engl J Med. 2004 Apr 8;350(15):1491-4. No abstract available.

PMID:
15071124
5.

Statins, high-density lipoprotein, and the low-density lipoprotein/high-density lipoprotein ratio.

Silva JM.

Am J Cardiol. 2000 Sep 1;86(5):593-4. No abstract available.

PMID:
11009292
6.

Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.

deGoma EM, Leeper NJ, Heidenreich PA.

J Am Coll Cardiol. 2008 Jan 1;51(1):49-55. doi: 10.1016/j.jacc.2007.07.086.

7.

Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

Cui Y, Watson DJ, Girman CJ, Shapiro DR, Gotto AM, Hiserote P, Clearfield MB.

Am J Cardiol. 2009 Sep 15;104(6):829-34. doi: 10.1016/j.amjcard.2009.05.020.

PMID:
19733719
8.

The statin era: in search of the ideal lipid regulating agent.

Shepherd J.

Heart. 2001 Mar;85(3):259-64. No abstract available.

9.

HDL: back to the drawing board.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2007 May;19(3):1-2. No abstract available.

PMID:
17657883
10.

Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin.

Krikken JA, Waanders F, Dallinga-Thie GM, Dikkeschei LD, Vogt L, Navis GJ, Dullaart RP.

Expert Opin Ther Targets. 2009 May;13(5):497-504. doi: 10.1517/14728220902905865 .

PMID:
19397474
11.

Keeping our eyes on the prize: low density lipoprotein cholesterol.

de Lemos JA, Khera A.

Am J Cardiol. 2009 Dec 15;104(12):1697-8. doi: 10.1016/j.amjcard.2009.07.052. No abstract available.

PMID:
19962478
12.

Is a blood pressure rise the only deleterious off-target effect of cholesterol ester transfer protein inhibitors?

Miura S, Saku K.

J Hypertens. 2010 Aug;28(8):1614-6. doi: 10.1097/HJH.0b013e32833c575b. No abstract available.

PMID:
20647856
13.

LDL-Cholesterol is the King.

Goumas GS.

Angiology. 2009 Jun-Jul;60(3):387-8. doi: 10.1177/0003319709334121. Epub 2009 Jun 3. No abstract available.

PMID:
19497926
14.

Clinical trials and tribulations. Cholesterol veers off script.

Couzin J.

Science. 2008 Oct 10;322(5899):220-3. doi: 10.1126/science.322.5899.220. No abstract available.

PMID:
18845747
15.

Statin pharmacology may have important clinical implications.

[No authors listed]

Am J Manag Care. 2002 Jul;Suppl Symposium Reporter:2, 5. No abstract available.

16.

Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied.

Masterjohn C.

Am Heart J. 2009 Jul;158(1):e11; author reply e13. doi: 10.1016/j.ahj.2009.05.004. No abstract available.

PMID:
19540377
17.

Dissociating HDL cholesterol from cardiovascular risk.

Hausenloy DJ, Opie L, Yellon DM.

Lancet. 2010 Jul 31;376(9738):305-6. doi: 10.1016/S0140-6736(10)61021-5. Epub 2010 Jul 23. No abstract available.

PMID:
20655104
18.

Achieving cholesterol goals. Current and future drug therapies.

Jones PH.

Postgrad Med. 2003 Aug;114(2 Suppl):14-21. doi: 10.3810/pgm.08.2003.suppl28.152.

PMID:
19667635
19.

Who should receive statin therapy among the elderly?

Desilvey DL.

Am J Geriatr Cardiol. 2006 Mar-Apr;15(2):122. No abstract available.

PMID:
16525228
20.

Medications that lower low-density lipoprotein (LDL) cholesterol and non–high-density lipoprotein (non-HDL) cholesterol.

Brown WV.

J Clin Lipidol. 2012 Mar-Apr;6(2):95. doi: 10.1016/j.jacl.2012.01.005. Epub 2012 Jan 28. No abstract available.

PMID:
22385540

Supplemental Content

Support Center